Jay M Young

Summary

Country: USA

Publications

  1. ncbi request reprint Efficacy and safety of sildenafil citrate (Viagra) in black and Hispanic American men
    Jay M Young
    South Orange County Urological Medical Associates, Laguna Woods, California 92653, USA
    Urology 60:39-48. 2002
  2. ncbi request reprint Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial
    Jay M Young
    South Orange County Medical Research Center, 24301 Paseo de Valencia, Suite 100 Laguna Woods, CA 92653, USA
    J Androl 26:310-8. 2005
  3. ncbi request reprint Vardenafil
    Jay M Young
    South Orange County Medical Research Center, Laguna Woods, California 92653, USA
    Expert Opin Investig Drugs 11:1487-96. 2002
  4. ncbi request reprint Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study
    Irwin Goldstein
    Boston University Medical Center, Boston, Massachusetts 02118, USA
    Diabetes Care 26:777-83. 2003
  5. ncbi request reprint Efficacy and tolerability of vardenafil for treatment of erectile dysfunction in patient subgroups
    Hartmut Porst
    Urological Practice, Hamburg, Germany
    Urology 62:519-23; discussion 523-4. 2003
  6. ncbi request reprint Sustained efficacy and safety of vardenafil for treatment of erectile dysfunction: a randomized, double-blind, placebo-controlled study
    Luc Valiquette
    Service d Urologie, Hôpital St Luc du CHUM, 1058 rue Saint Denis, Montreal, Quebec, Canada
    Mayo Clin Proc 80:1291-7. 2005
  7. ncbi request reprint Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial
    Kevin T McVary
    Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611 3008, USA
    J Urol 177:1071-7. 2007
  8. ncbi request reprint Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia
    Kevin T McVary
    Department of Urology, Northwestern University Medical School, Chicago, Illinois 60611, USA
    J Urol 177:1401-7. 2007

Detail Information

Publications8

  1. ncbi request reprint Efficacy and safety of sildenafil citrate (Viagra) in black and Hispanic American men
    Jay M Young
    South Orange County Urological Medical Associates, Laguna Woods, California 92653, USA
    Urology 60:39-48. 2002
    ..These data demonstrate that despite differences in prevalence rates of comorbidities, efficacy and safety of sildenafil is maintained across different ethnic groups...
  2. ncbi request reprint Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial
    Jay M Young
    South Orange County Medical Research Center, 24301 Paseo de Valencia, Suite 100 Laguna Woods, CA 92653, USA
    J Androl 26:310-8. 2005
    ..The most common treatment-emergent adverse events were headache, back pain, dyspepsia, and nasopharyngitis. Both 10- and 20-mg tadalafil improved erectile function for up to 36 hours postdosing in men with ED of varied severity...
  3. ncbi request reprint Vardenafil
    Jay M Young
    South Orange County Medical Research Center, Laguna Woods, California 92653, USA
    Expert Opin Investig Drugs 11:1487-96. 2002
    ..Emphasis is placed on the presentation of data that demonstrates the clinical effectiveness and safety of this agent which is anticipated to be available in 2003...
  4. ncbi request reprint Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study
    Irwin Goldstein
    Boston University Medical Center, Boston, Massachusetts 02118, USA
    Diabetes Care 26:777-83. 2003
    ..This study evaluated the efficacy and safety of vardenafil treatment for erectile dysfunction (ED) in men with diabetes...
  5. ncbi request reprint Efficacy and tolerability of vardenafil for treatment of erectile dysfunction in patient subgroups
    Hartmut Porst
    Urological Practice, Hamburg, Germany
    Urology 62:519-23; discussion 523-4. 2003
    ..To assess whether vardenafil would improve erectile function irrespective of etiology, baseline severity, or patient age. The consistency of the response over time was also evaluated...
  6. ncbi request reprint Sustained efficacy and safety of vardenafil for treatment of erectile dysfunction: a randomized, double-blind, placebo-controlled study
    Luc Valiquette
    Service d Urologie, Hôpital St Luc du CHUM, 1058 rue Saint Denis, Montreal, Quebec, Canada
    Mayo Clin Proc 80:1291-7. 2005
    ..To evaluate the reliability, efficacy, and safety of vardenafil, 10 mg, for patients with erectile dysfunction...
  7. ncbi request reprint Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial
    Kevin T McVary
    Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611 3008, USA
    J Urol 177:1071-7. 2007
    ..We evaluated sildenafil for erectile dysfunction and lower urinary tract symptoms in men with the 2 conditions...
  8. ncbi request reprint Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia
    Kevin T McVary
    Department of Urology, Northwestern University Medical School, Chicago, Illinois 60611, USA
    J Urol 177:1401-7. 2007
    ..We assessed the efficacy and safety of tadalafil dosed once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia...